Abstract
Background and objectives
The evaluation of the severity of patients afflicted with major mental illness (MMI) has been problematic because of confounding variables and genetic variability. There have been multiple studies that suggest several human diseases, especially schizophrenia, are predisposed to be born in certain months or seasons. This observation implied an epigenetic effect of sunlight, likely ultraviolet radiation (UVR), which is damaging to DNA, especially in an embryo. This paper outlines a method to evaluate the severity of schizophrenia (SZ), bipolar disorder (BPD), and schizoaffective disorder (SZ-AFF) using the month/year of birth of those affected compared to the month/year of birth of the general population (GP).
Relevance
Our previous research found that more intense UVR (equal to or greater than 90 sunspot number (SSN)) had a negative effect on the average human lifespan. Also, human birth rates vary in frequency by month of birth reflecting variables like availability of food, sunlight, and other unknown epigenetic factors. We wanted to see if the patient month of birth varied from the average birth months of the general population and if UVR has an epigenetic effect promoting these diseases.
Methods
We obtained the month and year of birth of 1,233 patients admitted over a 15-year period to Maine's largest state psychiatric hospital and counted the months of birth for each diagnosis of SZ, BPD, and SZ-AFF, and compared these results to the general population's birth months of 4,265,555 persons from U. S. Census Year 2006. The number of patients in each month was normalized to August and compared with the normalized birth months of the general population (GP). Plots of the normalized months were considered rates of change (e.g., derivatives) and their respective integrals gave domains of each mental illness relative to the GP. Normalizing the GP to unity was then related to the factor 1.28, e.g., 28% more entropy, deduced from the Sun's fractal dimension imprinted on biological organisms.
Results
The percent of patients meeting our criterion for severity: SZ = 27%; BPD = 26%; SZ-AFF = 100%.
Conclusions
High UVR intensity or a rapid increase in UVR in early gestation are likely epigenetic triggers of major mental illness. BPD is more epigenetically affected than SZ or SZ-AFF disorders. We found that 52% of 1,233 patients comprised the core function of a tertiary-care psychiatric hospital. Also, mental illness exacerbated when the median SSN doubled. This work also validates the Kraeplinian dichotomy.
What is new in this research
This paper offers a new paradigm for evaluating the severity of MMI and supports significant epigenetic effects from UVR.
Keywords: Month of birth, Solar cycles, Epigenome, Schizophrenia, Bipolar disorder, Schizoaffective disorder, Ultraviolet radiation, Severity of illness, Sunspot number
Month of birth; Solar cycles; Epigenome; Schizophrenia; Bipolar disorder; Schizoaffective disorder; Ultraviolet radiation; Severity of illness; Sunspot number
1. Introduction
This paper offers a methodology to more objectively assess the severity of these three mental illnesses, schizophrenia (SZ), bipolar disorder (BPD) and schizoaffective disorder (SZ-AFF), using the intrinsic variation of solar radiation impressed on the epigenome-genome complex of all biological organisms. The literature on objectively assessing the severity of mental illness is not extensive [1]. Mainly noted are difficulties in defining severity of mental illness.
In the past two decades there have been many papers describing the effect of month and year of birth on the incidence of a variety of human diseases (see Table 1) [2]. Recently, a global meta-analysis reaffirmed that month of birth was associated with major mental disorders [3]. In addition, there is increasing interest in how environment affects the epigenome which controls the expression of the genetic library in DNA [4, 5]. In aquatic and terrestrial animals, as well as humans, many variables in the environment affect growth and development including temperature, food/nutrition, humidity, infections, gut microbiome, chemicals, ionizing radiation (radon, cosmic rays), and especially non-ionizing ultraviolet radiation (UVR) [6, 7, 8, 9]. Animal and plant life had to contend with genotoxic and mutagenic UVR from the Sun even after the formation of protective oxygen/ozone by stromatolites (cyanobacteria) in the pre-Cambrian Period [10, 11]. About 3% of ground-level solar radiation is UVR, of which about 95% lies in the UV-A (315–400 nm) spectrum and about 5% in the UV-B (280–315 nm) spectrum. Despite absorption by Earth's atmosphere, UVR is still a potent DNA/RNA mutagen, and over eons, organisms have developed efficient repair mechanisms to correct genotoxicity and maintain the integrity of DNA especially in meiotic organisms through the period of natural (sexual) selection [12, 13].
Table 1.
List of publications involving MOB and various diseases.
| CATEGORY | First Author (ref) | MOB | MOC | Comment |
|---|---|---|---|---|
| Lifespan/Life expectancy | ||||
| Lerchl, A. [83] | Increased Oct–Dec |
Jan–Mar | Decreased May–Jul |
|
| Gavrilov, L. A. [84] | Increased Sep–Nov |
Dec–Feb | centenarians | |
| Doblhammer, G. [85] | Autumn births | Jan–Mar | ||
| Lummaa, V. [86] | Nov–Mar, Jun | Feb–Jun, Sep | Fertility in 19th century | |
| Ueda, P. [87] | Mar–Apr | Jun–Jul | Increased cardiovascular mortality | |
| Ueda, P. [88] | Apr–May | Jul–Aug | Increased mortality in Sweden | |
| Abel, E. L. [89] | Increased Nov |
Mar | Decreased in Jun | |
| Multiple Sclerosis | ||||
| Dobson, R. [90] | Apr–May | Jul–Aug | ||
| Pantavou, K. [91] | Mar–May | Jun–Aug | Meta-analysis | |
| Staples, J. [92] | Nov–Dec | 1st -trimester Feb–Mar | (Southern Hemisphere) Higher incidence of MS |
|
| Akhtar, S. [93] | Dec | Mar | Study in Kuwait | |
| Celiac Disease | Capriati, T. [94] | Jun–Aug | Sep–Nov | ? related to gluten/rotavirus |
| Assa, A. [95] | May | Aug | Reduced risk: Dec- > Feb | |
| Atopy | ||||
| Nilsson, L. [96] | Sep–Feb | Dec–May | Less disease for those born in summer/spring | |
| Karachaliou, F.H. [97] | May–Aug | Aug–Nov | Study done in Greece | |
| Asthma | ||||
| Sargsyan, A. [98] | Oct–Dec | Jan–Mar | Pediatric patients | |
| Autism | ||||
| Lee, L. [99] | Mar, May, Sep | Jun, Aug, Nov | ||
| Lee, B. K. [100] | Sep–Nov | Dec–Feb | ||
| Shalev, H. [101] | Aug | Nov | ||
| Torrey, E. F. [27] | Mar | Jun | ||
| ADHD | ||||
| Sucksdorff, M. [102] | Nov–Mar | Low vitamin D in gestation | ||
| Diabetes mellitus type 1 | ||||
| Kahn, H. [103] | Apr–Jul | Jul–Oct | ||
|
Diabetes Mellitus Type 2 |
||||
| Grover, V. [104] | Oct is protective | Jan | African American cohort <18 yrs of age |
|
| Thyroiditis | ||||
| Thvilum, M. [105] | Jun | Sep | Autoimmune hypothyroidism | |
| Kyrgios, I. [106] | Mar | Jun | Lowest in Nov | |
| Colorectal cancer | ||||
| Francis, N. [107] | Sep | Dec | ||
| Narcolepsy | ||||
| Dauvilliers, Y. [108] | Mar | Jun | Trough in Sep | |
| Brain tumors | ||||
| Brenner, A. [109] | Jan–Feb | Apr–May | ||
| Nov–Mar | Feb–Jun | Left-handedness increased risk | ||
| Schmidt, L. [110] | Jan | Apr | ependymoma | |
| Hodgkin's disease | ||||
| Langagergaard, V. [111] | Mar | Jun | ||
| Non-Hodgkin's lymphoma | ||||
| Crump, C. [112] | Mar–Jun | Jun–Sep | Nadir in MOB Sep–Dec | |
| Melanoma | ||||
| Basta, N. [113] | Mar | Jun | Teenagers/young adults | |
| Lin, S–W. [114] | ||||
| IBS/Crohn's disease | ||||
| Van Ranst, M. [115] | Apr, Aug | Jul, Nov | Fewer cases in MOB Jun | |
| Depression | ||||
| Schnittker, J. [49] | Apr–Aug | Jul–Nov | Aggravated by poor nutrition | |
| Torrey, E. F. [27] | Mar–May | Jun–Aug | ||
| Schizophrenia/BP disorder | ||||
| Karlsson, H. [44] | Dec | Mar | Study from Sweden | |
| Davies, G. [116] | Jan–Mar | Apr–Jun | 27 Northern Hemisphere sites | |
| Torrey, E. F. [27] | Dec–Mar | Mar–Jun | ||
| Addison's disease | Pazderska, A. [117] | Dec | Mar | Trough in May |
| Malignant neoplasms | Stoupel, E. [118] | Jan–Apr | Apr–Jul | More males affected |
| Breast Cancer | Yuen, J. [119] | Jun | Sep | Study from Sweden |
Since 1993, several reports have emerged postulating the adverse effects of higher intensity UVR on human longevity; namely, peaks of approximately 11-year solar cycles (MAX) were particularly able to shorten lifespan, presumably due to the damaging effects of UVR [14,15]. Using the mortality data of approximately 63 million persons, we found an average 8-year reduction in human lifespan, e.g., more diseases, when the sunspot number (SSN), a surrogate for solar intensity, was equal to or greater than 90 at birth, the average SSN being approximately 40, however, greater than or equal to 90 SSN occurs only about 11% of the time. ADDIN EN.CITE [16, 17]. The most damaging UVR occurs in the 3-year portion of an 11-year solar cycle called the solar MAX where the number of sunspots are at the highest (approximately 160) of the solar cycle. Although less compelling than findings during solar MAX, others primarily report changes in seasonal or monthly UVR that modulate the incidence of various diseases (see Table 1).
There is increasing evidence that light, likely in the UVR spectrum through a variety of mechanisms, affects the human embryo [17, 18, 19]. Other papers propose the importance of early-life events that affect the incidence of disease in adult individuals [20, 21, 22]. The epigenome of the fetus is most sensitive not only to a variety of environmental factors, but also to many maternal influences possibly even to sunlight; e.g., UVR striking the mother's skin where vitamin D metabolism among other metabolic factors may play a role [18, 23, 24]. There is recent evidence that the gut microbiome may foster MMI due to the absorption of small molecules it produces that affect the gut-brain axis [25]. Abnormal circadian rhythms may also play a role in the developing embryo as chronodisruption has been linked to depression later in adulthood [26].
Torrey et. al. reported in 1996 that persons afflicted with a major mental illness (MMI) like SZ or BPD were more likely born in late winter and early spring [27]. Since then, other human disorders had seasonal birth predilections implying that varying solar radiation might be an important factor. That schizophrenia has a 1% incidence world-wide also suggests a global effect, not exclusively related to diet/nutrition, humidity, or even latitude [28]. Hypotheses that implicate Toxoplasmosis or influenza in the incidence of schizophrenia are plausible but are not necessarily uniformly distributed world-wide; however, UVR affects epigenomes, at least of surface organisms, universally. UVR is not always unhealthy as sun exposure is linked to a reduced pediatric risk for multiple sclerosis [29]. There is also evidence that specific diseases are mitigated by UVR, but overall UVR is detrimental [30, 31, 32]. Adequate production/absorption by UVR of the hormone vitamin D is salutary for the human immune system, but too much UVR is detrimental to human lifespan [33, 34].
We acquired the month of birth (MOB) records in the 2006 U. S. Census and found that births are not uniformly distributed as more occur in the summer and early fall. The reason for this observation is not totally known except that many animals conceive in the fall and give birth in the spring and early summer probably due the evolutionary imperative of increased newborn survival in more favorable weather and better food supplies. In this paper we use the number of births by month in the general population as a baseline to compare with persons afflicted with major mental illnesses. The null Hypothesis tested here is that major mental illness is not related to month of birth or MAX or MIN.
Hypothesis #1
We hypothesize that the deviation of MOB of persons with MMI varies from that of the GP is a measure of the epigenetic effect of UVR at conception/early gestation, and evident at birth. We assume that the GP is, on average, ideally adapted to the UVR environment and alterations in MOB may be maladaptive due to varying effects of UVR at conception/gestation when ectodermal tissues are in formation.
The most complicated, problematic patients in mental health find their way into tertiary care facilities because their behaviors are the most unpredictable and therefore dangerous to self or others. Assessment of the severity of MMI has been problematic and this paper offers a methodology to be more objective in this process [35]. Using 18 years of admission data from our former state hospital (the Augusta Mental Health Institute, we found that 72% of patients had a single admission, but the remaining 28% comprised admissions 2 through 12 (see Figure 1) [36]. Even at a tertiary facility the staff could not successfully “cure” those who expressed so much complexity, risk, and disorganized behavior that they required more than a single admission. Some of our single admissions sought care in other hospitals, but they did not meet strict requirements for readmission to our tertiary-care facility.
Evident in everyday life are macroscopic examples of 28% less entropy, or fewer possible states, including physical and mental states necessary to match the variety of states in the environment. The prevalence in the US population with either a MMI or a substance abuse disorder was 28.5% in 20,291 adults in the National Institute of Mental Health Epidemiologic Catchment Area Program indicating that portion of the population in a less adaptive state relative to the environment [37]. Using the representation of biological evolution created by the late British mathematician John Conway's Game of Life (a cellular automaton) revealed that the exponent of its power law was exactly 1.28 even after 100 million mutations reflecting the challenges changing environments force on biological systems [38]. It is likely that organisms must maintain a variation of no less than 28% in their genome-epigenome complex to maintain survivability over the long term. In the plant world pruning more than 28% of the living portion of a tree or scrub can jeopardize its survival [39]. We humans require about 7 h of sleep in a 24-hour period (for adults about 28% of the day) to maintain good health [40]. It probably is no accident that we also need 2 days out of a 7-day week (approximately 28%) for recreation. Note that entropy is system dependent. For example, entropy decreases with aging as there is less variation in heart rate, exercise tolerance, etc. (internal entropy)., but entropy increases rapidly at the time of death (external entropy).
Hypothesis #2
The more severe the mental disorder in our patients the larger the ratio of normalized birth month to the normalized (set to unity) birth month in the GP. That critical ratio is 1.28, above which indicates higher entropy relative to the environment (society), but internally (cerebrally) as in MMI, the ratio is less than 1.28 indicating lower entropy, e.g., fewer organized states available to match the environment.
The human brain is more complex than any machine invented by our species to date and is the most important organ for our survival. As such, the brain must be highly connected to our environment to preserve survival. It also manifests self-similarity on all scales like the branching of a tree, a property called “fractal”, a term coined by the late mathematician Benoit Mandelbrot [41]. Recall that a one-dimensional object (e.g., a line) has a fractal dimension value of unity. The “rougher” or more irregular the line, the greater the fractal dimension and the more complex the object. Probably not coincidentally, the Sun is a dynamical system with a generalized fractal dimension based on 10.7 cm radio fluxes (in Solar Cycle 21) of 1.28 for periods of about a week, and 1.30 for periods longer than 272 days [42]. While beyond the scope of this article, the Rényi entropy and fractals are connected by a linear relation (e.g., Sq = Dq lnr) [43]. If the fractal dimension approaches 2, a time series of radio fluxes becomes completely random [42].
The human brain has a fractal dimension of 1.60 (indicating more sulci; e.g., a cerebral cortex with more anatomical convolutions permitting more connections and probably higher intelligence) equal to approximately the square of the solar fractal dimension.
Figure 1.
Number of prior admissions (severity) versus the number of patients per group (frequency); example of a power law. [36].
2. Methodology
2.1. The data
We obtained the admission data from the Riverview Psychiatric Center (Maine's largest state psychiatric hospital) since the incept of a new computer system in 2006. The birth records go back to year 1974 from the previous state hospital (Augusta Mental Health Institute) to 2003 (Riverview Psychiatric Center) as no one under the age of 18 was admitted and only individuals were selected, omitting multiple admissions of the same patient. We only required deidentified birth month and birth year. We also had the NOAA data base for sunspot activity averaged by month and year, a surrogate for solar energy output. (See Supplement 1 SSN and Supplement 2 SSN) A total of 1,233 patients were available for analysis, 445 for SZ (36% of total), 358 for BPD (29% of total), and 430 for SZ-AFF (35% of total). Of the SZ-AFF patients most were classified as “undifferentiated”, but 98 (23%) of the 430 patients were classified “bipolar type”. Only a few were classified “depressed type”. We did not include patients with borderline or antisocial personality disorders as the primary diagnosis. No major depressive disorder diagnoses were included in this paper because most are successfully treated at primary and secondary psychiatric hospitals. We also acquired the MOB data for the year 2006 U. S. Census, N = 4,265,555, a year during a solar MIN, average SSN = 15, and serves as a good baseline for distribution of MOB with no sustained high UVR. Another author has used the GP as a baseline [44].
The data were supplied in alphanumerical order, for example, Jan 1984, and were first sorted for year of birth (YOB) to match SSN with that month and year from the NOAA SSN data. Then each month was given a numeric value, for example, numeral 1 for January, numeral 2 for February, etc., and then sorted from 1 to 12 and each of the twelve months counted for the number of patients born in their respective months (see Tables 2a and 2b). The next step normalized each diagnosis to the month of August creating ratios to compare our data with the larger GP, also normalized to the month of August (see Tables 3a and 3b). We use the birth month/year data in the 2006 U. S. Census to serve as a reference because that population is on average adapted to the environment, and we hypothesize deviation from that average is maladaptive. We also calculated the average, median and standard deviation of SSN for the whole set for each diagnosis and for the separate greater than or equal to 90 SSN sets (see Table 4a, 4th column).
Table 2a.
Number of patients by Month of Birth and Diagnosis at Riverview (MOB from years 1974–2003, collected from 2004 to present).
| MOB | Schizophrenia | Bipolar Disorder |
Schizoaffective Disorder |
General population (2006) |
|---|---|---|---|---|
| Jan | 40 | 28 | 40 | 340,297 |
| Feb | 29 | 27 | 37 | 319,235 |
| Mar | 47 | 34 | 51 | 356,786 |
| Apr | 40 | 32 | 31 | 329,809 |
| May | 48 | 25 | 49 | 355,437 |
| Jun | 29 | 37 | 37 | 358,251 |
| Jul | 36 | 23 | 40 | 367,934 |
| Aug | 33 | 30 | 31 | 387,798 |
| Sep | 38 | 37 | 42 | 374,711 |
| Oct | 33 | 28 | 37 | 367,354 |
| Nov | 26 | 28 | 33 | 351,832 |
| Dec | 46 | 29 | 42 | 356,111 |
| Totals | 445 (36%) | 358 (29%) | 430 (35%) | 4,265,555 |
| N ≥90 SSN | 185 (42%) | 114 (32%) | 189 (44%) | None ≥90 SSN |
Table 2b.
Number of patients by Month of Birth for ≥90 SSN.
| MOB | Schizophrenia | Bipolar disorder | Schizoaffective disorder |
|---|---|---|---|
| Jan | 15 | 7 | 14 |
| Feb | 11 | 8 | 11 |
| Mar | 20 | 12 | 18 |
| Apr | 8 | 11 | 14 |
| May | 15 | 6 | 21 |
| Jun | 12 | 15 | 18 |
| Jul | 16 | 6 | 10 |
| Aug | 12 | 8 | 12 |
| Sep | 16 | 16 | 21 |
| Oct | 12 | 11 | 14 |
| Nov | 28 | 5 | 18 |
| Dec | 20 | 9 | 18 |
| Totals | 185 | 114 | 189 |
Table 3a.
Normalized Month of Birth data from Table 2a.
| MOB | Schizophrenia | Bipolar disorder | Schizoaffective disorder | General population |
|---|---|---|---|---|
| Jan | 1.21 | 0.93 | 1.29 | 0.88 |
| Feb | 0.88 | 0.90 | 1.19 | 0.82 |
| Mar | 1.42 | 1.13 | 1.65 | 0.92 |
| Apr | 1.21 | 1.07 | 1.00 | 0.85 |
| May | 1.45 | 0.83 | 1.58 | 0.92 |
| Jun | 0.88 | 1.23 | 1.19 | 0.92 |
| Jul | 1.09 | 0.77 | 1.29 | 0.95 |
| Aug | 1.00 | 1.00 | 1.00 | 1.00 |
| Sep | 1.15 | 0.83 | 1.35 | 0.97 |
| Oct | 1.00 | 0.93 | 1.19 | 0.95 |
| Nov | 0.79 | 0.93 | 1.06 | 0.91 |
| Dec | 1.39 | 0.97 | 1.35 | 0.92 |
Table 3b.
Normalized MOB data for Diagnoses ≥90 SSN from Table 2b.
| MOB | Schizophrenia ≥90 SSN |
Bipolar disorder ≥90 SSN |
Schizoaffective disorder ≥90 SSN |
|---|---|---|---|
| Jan | 1.25 | 0.88 | 1.17 |
| Feb | 0.92 | 1.00 | 0.92 |
| Mar | 1.67 | 1.50 | 1.50 |
| Apr | 0.67 | 1.38 | 1.17 |
| May | 1.25 | 0.75 | 1.75 |
| Jun | 1.00 | 1.88 | 1.50 |
| Jul | 1.33 | 0.75 | 0.83 |
| Aug | 1.00 | 1.00 | 1.00 |
| Sep | 1.33 | 2.00 | 1.75 |
| Oct | 1.00 | 1.38 | 1.17 |
| Nov | 1.08 | 0.63 | 1.50 |
| Dec | 1.67 | 1.13 | 1.50 |
Table 4a.
Data for all diagnoses and their ≥90 SSN subsets.
| Diagnosis | Integral | Differential inflection(s) by month | average/median/SD of SSN | ratio/gen pop Low high |
|---|---|---|---|---|
| Schizophrenia | 11.50 | 4.0, 9.0 | 75/60/59 | 1.04 1.28 |
| SZ ≥90 SSN | 12.65 | 2.4, 7.8 | 141/137/35 | 1.13 1.57 |
| Bipolar disorder | 10.28 | 9.0 | 71/58/54 | 0.95 1.10 |
| BPD ≥90 SSN | 13.35 | 7.0 | 138/136/31 | 1.19 1.44 |
| General population | 9.92 | 1.5, 8.0 | Average SSN = 15 (at Solar minimum) | 1.00 1.00 |
| SZ-AFF disorder | 14.04 | 3.5, 9.0 | 78/65/59 | 1.27 1.57 |
| SZ-AFF ≥90 SSN | 14.70 | 4.5, 8.0 | 140/131/36 | 1.33 1.80 |
Using Excel and Tables 3a and 3b, we then created trend (goodness-of-fit) lines using third-degree polynomials for each of the three psychiatric diagnoses and for the GP (see Figure 2). We considered these trend lines to be rate-of-change plots, essentially derivatives. The trend line equations were then integrated for their total area under the curves (producing whole domains in the difference in MOB distribution from the GP for each diagnosis) for each monthly interval, (Jan–Feb, Feb–Mar, etc.). To check on accuracy, each of the 11 partitions added up within one-hundredth decimal accuracy to the total 1–12 integral for each diagnosis (See Tables 4a, 4b).
Figure 2.
Trend lines by month of birth for patients with Schizophrenia, bipolar disorder, schizoaffective disorder and for the general population (2006 Census). Trend-line equations in Figure 2 (each subsequently integrated):
Schizophrenia: y = 0.0023x3 - 0.0449x2 + 0.2442x + 0.7242 (R2 = 0.1212); N = 445
Schizophrenia ≥90 SSN: y = 0.0017x3 – 0.0257x2 + 0.0924x + 1.0935 (R2 = 0.159); N = 170
Schizoaffective: y = 0.0018x3 – 0.0337x2 + 0.1643x + 1.1241 (R2 = 0.1286); N = 430
Schizoaffective ≥90 SSN: y = 0.0027x3 – 0.052x2 + 0.3061x + 0.7955 (R2 = 0.1461); N =189
Bipolar Disorder: y = 9E-05x3 – 0.0042x2 + 0.0421x + 0.8976 (R2 = 0.0339); N = 358
Bipolar Disorder ≥90 SSN: y = -6E-05x3 – 0.0103x2 + 0.1479x + 0.8195 (R2 = 0.0827); N = 114
General population (2006 census; N = 4,265,555):
y = -0.0006x3 + 0.0089x2 -0.0249x + 0.8805 (R2 = 0.6744).
Table 4b.
Bimonthly integrals with totals.
| Months Disease |
Jan–Feb | Feb–Mar | Mar–Apr | Apr–May | May–Jun | Jun–Jul | Jul–Aug | Aug–Sep | Sep–Oct | Oct–Nov | Nov–Dec | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schizophrenia | 0.99 | 1.09 | 1.13 | 1.12 | 1.09 | 1.05 | 1.00 | 0.97 | 0.97 | 1.00 | 1.10 | 11.51 |
| SZ ≥90 SSN | 1.18 | 1.19 | 1.17 | 1.14 | 1.11 | 1.08 | 1.06 | 1.07 | 1.11 | 1.20 | 1.35 | 12.66 |
| Bipolar | 0.82 | 0.85 | 0.88 | 0.91 | 0.94 | 0.97 | 0.99 | 1.00 | 1.00 | 0.98 | 0.95 | 10.29 |
| BPD ≥90 SSN | 1.02 | 1.12 | 1.21 | 1.27 | 1.31 | 1.33 | 1.32 | 1.29 | 1.24 | 1.17 | 1.07 | 13.35 |
| SZ-AFF | 1.30 | 1.35 | 1.36 | 1.34 | 1.31 | 1.26 | 1.22 | 1.19 | 1.19 | 1.22 | 1.30 | 14.04 |
| SZ-AFF ≥90 SSN | 1.14 | 1.28 | 1.34 | 1.36 | 1.35 | 1.33 | 1.31 | 1.30 | 1.33 | 1.40 | 1.55 | 14.69 |
| General population | 0.86 | 0.86 | 0.88 | 0.89 | 0.91 | 0.93 | 0.94 | 0.94 | 0.93 | 0.90 | 0.86 | 9.92 |
Dividing each of the 11 partition integrals in Table 4b by the respective GP integral, yielded the values in Table 4c, effectively normalizing to the GP. The plots in Figures 3, 4, and 5 (using data from Table 4c) give the severity of illness (extent of deviation from the GP) for the three diagnoses relative to a Y-axis value of 1.00, the reference to the GP. In this paper we use the average duration of human gestation to be 280 days, or 40 weeks, from the first day of a woman's last menstrual period. Therefore, we considered the month of conception (MOC) to be 10 months prior to MOB.
Table 4c.
Bimonthly integrals/integral of the general population.
| Months Disease |
Jan–Feb | Feb–Mar | Mar–Apr | Apr–May | May–Jun | Jun–Jul | Jul–Aug | Aug–Sep | Sep–Oct | Oct–Nov | Nov–Dec | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schizophrenia | 1.15 | 1.27 | 1.28 | 1.26 | 1.20 | 1.13 | 1.06 | 1.03 | 1.04 | 1.11 | 1.28 | 1.16 |
| SZ ≥90 SSN | 1.37 | 1.38 | 1.33 | 1.28 | 1.22 | 1.16 | 1.13 | 1.14 | 1.19 | 1.33 | 1.57 | 1.28 |
| Bipolar | 0.95 | 0.99 | 1.00 | 1.02 | 1.03 | 1.04 | 1.05 | 1.06 | 1.08 | 1.09 | 1.10 | 1.04 |
| BPD ≥90 SSN |
1.19 | 1.30 | 1.38 | 1.43 | 1.44 | 1.43 | 1.40 | 1.37 | 1.33 | 1.30 | 1.24 | 1.35 |
| SZ-AFF | 1.51 | 1.57 | 1.55 | 1.51 | 1.44 | 1.35 | 1.30 | 1.27 | 1.28 | 1.36 | 1.51 | 1.42 |
| SZ-AFF ≥90 SSN | 1.33 | 1.49 | 1.52 | 1.53 | 1.48 | 1.43 | 1.39 | 1.38 | 1.43 | 1.56 | 1.80 | 1.49 |
Figure 3.
Schizophrenia- Bimonthly integrals normalized to the general population (1.00 on plot) Y-axis ≥ 1.28 being critically severe.
Figure 4.
bipolar disorder- Bimonthly integrals normalized to the general population (1.00 on plot) Y-axis ≥ 1.28 being critically severe.
Figure 5.
Schizoaffective disorder- Bimonthly integrals normalized to the general population (1.00 on plot) Y-axis ≥ 1.28 being critically severe.
3. Results
3.1. Schizophrenia
Referring to Figure 3 created from the data in Table 4c:
Note that the full data set is below the critical severity level of 1.28 (Mar–Apr and Nov–Dec integrals are exactly 1.28). Looking at the greater than or equal to 90 SSN plot reveals essentially the same pattern but more severe illness in the late winter and early spring and an even higher peak during the November–December interval. Calculations of the most ill patients based upon the level above 1.28 in the greater than or equal to 90 SSN plot:
All >1.28 integral ratios in the SZ greater than or equal to 90 SSN set add up from January through May: 1.37 + 1.38 + 1.33 + 1.28 = 5.36, plus October–November and November–December: 1.33 + 1.57 = 2.90. Summing: 5.36 + 2.90 = 8.26 which is 8.26/12.65 = 0.65 (65%) of the total integral (in 2nd column of Table 4a).
Since there were 185 patients in the greater than or equal to 90 SSN set, 185 x 0.65 = 121 patients.
121/445 total schizophrenic patients = 0.27 or 27% of those afflicted with schizophrenia are more complicated and likely to have a longer length-of-stay (LOS).
Referring to the second column in Table 4a, we take the ratio of the total integrals for the full 12 months of SZ greater than or equal to 90 SSN/SZ = 12.65/11.50 = 1.10. Therefore, there is 10% epigenetic component, leaving 90% genetic. We consider those born in greater than or equal to 90 SSN as influenced epigenetically.
3.2. Bipolar disorder
Referring again to Figure 4 created from Table 4c:
All >1.28 ratios are in the BPD greater than or equal to 90 SSN set except for January & February in that set: 1.19 and November–December: 1.35 Subtract (1.19 + 1.35 =) 2.54 from the total integral 13.35 or 10.81. This divided by the total integral (2nd column of Table 4a) for greater than or equal to 90 SSN: 10.81/13.35 = 0.81; 0.81 x 114 patients = 92 patients. Of the total BPD patients, 92/358 = 26% of the BPD patients are more complicated and likely to have a longer LOS. If we take the ratio of the total integrals for the full 12 months, BPD greater than or equal to 90 SSN/BPD = 13.35/10.28 = 1.30. Therefore, there is a 30% epigenetic component, three times that of schizophrenia, still leaving a substantial 70% genetic fraction.
3.3. Schizoaffective disorder
Referring to Figure 5 created from Table 4c:
All integrals are >1.28 for both SZ-AFF and the SZ-AFF greater than or equal to 90 SSN sets.
14.70/14.70 = 1.0 or 100% or all 430 patients are more complicated, probably with the longest LOS. If we take the ratio of the total integrals for the full 12 months, SZ-AFF greater than or equal to 90 SSN/SZ-AFF = 14.70/14.04 = 1.05. Therefore, there is only a 5% epigenetic component suggesting that 95% of this disease is genetically canalized (according to Hallgrimsson, “canalization is the tendency for the development of a specific genotype to follow the same trajectory under different environments or different genetic backgrounds” [45].
To calculate the total of the most complex (e.g., physically as well as mentally) using the numbers in bold type above with the total number of patients being 1,233:
121 + 92 + 430 = 643 and 643/1233 = 0.52 or 52% of our state hospital's population is significantly more ill, more expensive, and likely the main reason for the existence of a tertiary psychiatric care facility.
An assessment of the total LOS in our hospital of thirty randomly selected patients for each diagnosis of SZ, BPD, and SZ-AFF disorder were as follows:
Schizophrenia: 10,279 days; Bipolar disorder: 13,591 days; Schizoaffective disorder: 22,769 days. (LOS includes a period of “convalescent status” outside the hospital for those patients with more severe symptoms and behaviors that require longer oversight).
If we assume that LOS is approximately proportional to severity of illness, the relative severity-of-illness estimates using the above LOSs: 1.32 (BPD patients are about 1/3 more ill than SZ patients); 2.22 (SZ-AFF patients are 2x more ill than SZ patients); 1.68 (SZ-AFF patients are about 2/3rds more ill than BPD patients).
Although SZ and BPD are nearly equal in complexity based on our severity metric, the SZ-AFF patients are clearly the most complicated.
Note in Table 4a (4th column) that the median SSN for all three of the diseases studied here varies from 58 to 65 with the median equaling 60 (the average = 75, the SD = 55) (from the Supplement) from 1974 through 2002 (29 years) encompassing the birth years of our patients. The UVR dose for SZ greater than or equal to 90, 137/60 = 2.3 times greater than baseline; for BPD greater than or equal to 90 SSN, 136/58 = 2.3 times greater than baseline, and for SZ-AFF greater than or equal to 90 SSN, 131/65 = 2.0 times greater than baseline. Therefore, epigenetic effects in these psychiatric diseases become more apparent when the baseline UVR doubles in intensity. While infrared radiation is the most abundant electromagnetic radiation striking Earth as heat, according to quantum mechanics, UVR photons (mostly UV-A) have twice the energy of infrared photons and therefore our greater than or equal to 90 SSN set endures 4 times the potentially genotoxic energy compared to the less than 90 SSN set.
4. Discussion
There is significant difficulty quantifying the severity of psychiatric disease [46]. This paper offers a methodology to more objectively assess the severity of MMI based only on month and year of birth and SSN. While LOS is an indicator of the average severity of illness, our methodology parses out those patients whose epigenomes are especially affected by solar energy resulting in more severe mental illness. We were stimulated to look at MMI after 15 years of observation and noted that several patients, especially those with BPD, were born in solar cycle MAX. Our previous work demonstrated an epigenetic effect of UVR on average human lifespan and we were curious to see if a similar effect played a role in MMI. There are many potential external influences on our epigenome, a major one currently being the microbiome, and we have not ruled out an effect of circadian disruption (probably in the mother) which could alter the phenotypic expression of mental disorders. Our paper discusses one of these influences, e.g., UVR, which affects humans universally all over the world. In addition, confounding epigenetic influences are somewhat mitigated as 80% of our patients are comorbid for sexual/physical abuse, childhood malnutrition, substance abuse, and suicidal ideation.
One Hypothesis in this paper is that deviation of MOB from the average MOB distribution in the GP is a measure of the effect of UVR on the human epigenome at birth, but also at conception and early gestation [47]. ADDIN EN.CITE.
4.1. Schizophrenia
The peak MOB is known to be late winter and early spring, in February through April when MOC (10 months before birth) occurs in May, June and July around the summer solstice. What is not well-known, but seen in our data, is the peak MOB in November–December when MOC occurs at the spring equinox when UVR rapidly increases [44]. The embryonic/fetal central nervous system (CNS) is stimulated both from high-constant or rapidly-increasing UVR, apparently abetting schizophrenia with its known significant genetic loading. Environmental conditions at MOC are likely more important than at MOB because of the sensitivity of the embryo [48, 49].
Although fewer in number, persons having the deficit (negative) symptom type of SZ, who express avolition and diminished emotion, are seen in Figure 3 as a birth nadir in months August and September [50]. This corresponds to MOC at the winter solstice when UVR is at its lowest. The low ratio reflects the lack of positive (paranoid, externally aggressive) symptoms in SZ perceived by society as more unpredictable states [51]. However, negative symptoms are more resistant to treatment, have more white matter brain changes, and have a higher incidence in relatives [52, 53, 54].
4.2. Bipolar disorder
The average severity level is 4% above the GP and the highest value is 10% in November–December. We hypothesize that this relatively low level of severity above the GP may indicate that genes involved in BPD may be selected for in milder forms of the disease because of the associated creativity, intelligence, and productivity [55, 56, 57, 58, 59, 60]. For BPD greater than or equal to 90 SSN the level of severity is at its maximum about 30% more severe than the full set. Epigenetic effects are particularly important in BPD [61].
Note that the greater than or equal to 90 SSN BPD set has a different shape than the full set. The peak falls in the months of May–Jun equivalent to the MOC at the autumnal equinox when UVR is rapidly decreasing and could abet the depression which characterizes the most common and disabling state of persons with BPD [62, 63]. This parallels the process of symptom onset in seasonal affective disorder (SAD) in which decreasing UVR evidently triggers the onset of depressive symptoms [64]. As seen in Figure 4, MOB effects in BPD are subtle and are only readily seen in only about one-third of the whole set with SSN greater than or equal to 90. Others have not been able to appreciate MOB effects when taking the whole BPD set [65].
4.3. Schizoaffective disorder
Since its inception as a diagnostic term in 1933 by Kasanin, it has caused consternation as it straddles the line between affective and psychotic disorders and challenges the Kraeplinian dichotomy paradigm [46, 66, 67, 68, 69, 70]. Figure 5 has the same general shape as schizophrenia in Figure 3 but is scaled to a higher ratio, e.g., more ill, and appears to give credence to the argument that SZ-AFF is more consistent with a primarily psychotic process than a mood disorder. This conclusion is supported by other researchers [71]. This is interesting because the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) says that the mood symptoms are “present for the majority of the total duration of the active and residual portions of the illness.” In other words, the mood disorder component is emphasized over the psychotic component. Others suggest that psychotic and mood symptoms lie on a spectrum [46]. Our data suggest that the opposite is true; namely, the SZ-AFF is primarily a psychotic process as Figure 3 and Figure 5 more closely align with those of SZ than BPD. The different patterns observed between BPD compared to SZ and SZ-AFF also provide strong evidence in support of the Kraeplinian dichotomy, suggesting that there are two main categories of MMI, psychotic and mood [72]. The main reason for theorizing that SZ-AFF is a mood disorder is the response to lithium not seen in SZ [73]. Both the general and greater than or equal to 90 SSN sets are above the critical severity metric 1.28 and are the most ill psychiatric patients as corroborated by our LOS data.
4.4. The sun affects the epigenomes of surface organisms
After 3.8 billion years of biological evolution, it should not be surprising that the patterns of radiation from our variable Sun somehow affect the epigenomes of most, if not all, surface organisms. Our brain is the organ most responsible for human adaptability in an ever-changing environment. The fractal (self-similar at all scales) feature of solar radiation is manifest in the human brain as another fractal. e.g., 1.28 x 1.28 = 1.64, which is close to the reported 1.60 fractal dimension of the human brain [74]. We speculate that human dominance in the biological world may be in having a brain that effectively squares the solar fractal dimension of 1.28.
Solar physicists now predict that we may be entering a Grand Minimum when we perhaps will not see another Solar MAX for the next 50–100 years. However, lower doses of UVR may be beneficial to those with genetic loading for the psychiatric illnesses and with less of an epigenetic trigger to genetic loading, we may see less phenotypic expression of the psychiatric illnesses studied in this paper.
Of course, a most compelling question is how UVR affects the mother, which in turn, affects the embryo. Reptiles (e.g., chameleons), amphibians (e.g., frogs), and cephalopods (e.g., cuttlefish) have skin chromatophores that detect light and connect to the nervous system to improve survival [75]. The human embryo studied in artificial implantation procedures can be damaged by blue and long wavelength UV-A light [76]. More recently, in mice thermogenesis is enhanced by opsin-3-dependent adipocyte light sensing [77]. We hypothesize that T-lymphocytes circulating through the maternal skin, or cytokines triggered by UVR, carry information via the placenta to the fetal thymus [78]. Certainly, some mechanism must exist and is the subject of ongoing research [79]. In high, or rapidly increasing UVR, fetal ectoderm may be epigenetically “prewired” to future external environmental threats, and in persons with significant genetic loading for MMI, the developing CNS might be detrimentally overstimulated.
It is premature to prescribe recommendations about exposure to UVR during pregnancy, but we predict that altering UVR conditions at conception and early gestation would have a greater effect than similar exposures after puberty or in adulthood [80]. For example, if there is significant genetic loading, e.g., a schizophrenic family history, it might be advisable to avoid conception at the spring equinox (e.g., rapidly increasing UVR) or the summer solstice (highest UVR). The methodology used in this paper could be useful in identifying those who might become prodromal for MMI, an endeavor intensively studied over the past several years [81, 82].
5. Conclusions
Using Hypotheses #1 and #2 outlined in this paper, we conclude:
-
•
High UVR intensity or a rapid increase in UVR promote expression of phenotypic SZ, BPD, and SZ-AFF disorders. Epigenetic effects in these genetically predisposed diseases become more apparent when the median SSN doubles, implying double UVR intensity.
-
•
Epigenetic effects in BPD are 3 times greater than in SZ and 6 times greater than in SZ-AFF.
-
•
SZ-AFF is least affected by high UVR, e.g., greater than or equal to 90 SSN, suggesting that this disorder is more canalized in the genome. The patients with this diagnosis are the most ill.
-
•
Environmental UVR at MOC or early gestation is likely more important than MOB in influencing phenotypic expression of MMI, reflecting the sensitivity of the embryo.
-
•
Using the increased entropy factor of 1.28 imposed by solar metabolism, we found that over half of our inpatients are especially unpredictable and expensive, supporting the need for tertiary psychiatric care.
-
•
Our methodology validates the Kraeplinian dichotomy between psychosis and mood disorders.
-
•
The mechanism of how maternal exposure to UVR affects the conceptus is yet to be determined, but such a mechanism must exist.
6. Limitations of the study
Despite 15 years of admissions, the study could benefit from a larger N by including similar patients from other state hospitals. Our patients were largely Caucasian and were the most ill in the state, not the average patient. Maine has moderate seasonal variation being at approximately 44° N latitude. The United Kingdom and Scandinavia are approximately 10° higher in latitude and it would be interesting to obtain data from these areas of greater variation and less UVR intensity.
7. Advantages of the study
We used simple calculations with readily available deidentified data. Patients were mostly from Maine, but many have come from other states and other countries averaging confounders like nutrition, temperature, and latitude. UVR affects the entire planet.
8. Future work
We would like to obtain data on major depressive disorder from secondary psychiatric facilities to compare severity of illness metrics with the plots in this paper. The acquisition of similar deidentified inpatient or outpatient data of psychiatric diseases, not usually seen in a tertiary psychiatric facility, could be instructive. We would also like to study multiple sclerosis, the quintessential autoimmune disease related to changing UVR/latitude.
Ethics approval and consent to participate
No data required consent as there were no identifiers. No specific human or animal subjects were required.
Declarations
Author contribution statement
George Edward Davis: Conceived and designed the experiments; Performed the experiments; Wrote the paper.
Matthew J. Davis: Contributed reagents, materials, analysis tools or data.
Walter E. Lowell: Analyzed and interpreted the data.
Funding statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Data availability statement
Data included in article/supplementary material/referenced in article.
Declaration of interests statement
The authors declare no conflict of interest.
Additional information
No additional information is available for this paper.
Acknowledgements
We appreciate the help of Samantha R. Brockway, RHIT, head of our medical records department, in obtaining patient data. We also thank the several colleagues who read drafts and gave suggestions to clarify the manuscript.
Appendix A. Supplementary data
The following is the supplementary data related to this article:
References
- 1.Slade M., Powell R., Rosen A., Strathdee G. Threshold Assessment Grid (TAG): the development of a valid and brief scale to assess the severity of mental illness. Soc. Psychiatr. Psychiatr. Epidemiol. 2000;35:78–85. doi: 10.1007/s001270050011. [DOI] [PubMed] [Google Scholar]
- 2.Boland M.R., Shahn Z., Madigan D., Hripcsak G., Tatonetti N.P. Birth month affects lifetime disease risk: a phenome-wide method. J. Am. Med. Inf. Assoc. 2015;22:1042–1053. doi: 10.1093/jamia/ocv046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hsu C.W., Tseng P.T., Tu Y.K., Lin P.Y., Hung C.F., Liang C.S., Hsieh Y.Y., Yang Y.H., Wang L.J., Kao H.Y. Month of birth and mental disorders: a population-based study and validation using global meta-analysis. Acta Psychiatr. Scand. 2021 doi: 10.1111/acps.13313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Roy S. Impact of UV radiation on genome stability and human health. Adv. Exp. Med. Biol. 2017;996:207–219. doi: 10.1007/978-3-319-56017-5_17. [DOI] [PubMed] [Google Scholar]
- 5.Bauer M., Glenn T., Alda M., Andreassen O.A., Angelopoulos E., Ardau R., Baethge C., Bauer R., Baune B.T., Bellivier F., et al. Influence of light exposure during early life on the age of onset of bipolar disorder. J. Psychiatr. Res. 2015;64:1–8. doi: 10.1016/j.jpsychires.2015.03.013. [DOI] [PubMed] [Google Scholar]
- 6.Cummings D.R. Human birth seasonality and sunshine. Am. J. Hum. Biol. 2010;22:316–324. doi: 10.1002/ajhb.20987. [DOI] [PubMed] [Google Scholar]
- 7.Madan A., Thompson D., Fowler J.C., Ajami N.J., Salas R., Frueh B.C., Bradshaw M.R., Weinstein B.L., Oldham J.M., Petrosino J.F. The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness. J. Affect. Disord. 2020;264:98–106. doi: 10.1016/j.jad.2019.12.020. [DOI] [PubMed] [Google Scholar]
- 8.Quintana-Murci L. Genetic and epigenetic variation of human populations: an adaptive tale. C R Biol. 2016;339:278–283. doi: 10.1016/j.crvi.2016.04.005. [DOI] [PubMed] [Google Scholar]
- 9.Bosman E.S., Albert A.Y., Lui H., Dutz J.P., Vallance B.A. Skin exposure to narrow band ultraviolet (UVB) light modulates the human intestinal microbiome. Front. Microbiol. 2019;10:2410. doi: 10.3389/fmicb.2019.02410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ries G., Heller W., Puchta H., Sandermann H., Seidlitz H.K., Hohn B. Elevated UV-B radiation reduces genome stability in plants. Nature. 2000;406:98–101. doi: 10.1038/35017595. [DOI] [PubMed] [Google Scholar]
- 11.Oliveira R.J., Mantovani M.S., Silva A.F., Pesarini J.R., Mauro M.O., Ribeiro L.R. Compounds used to produce cloned animals are genotoxic and mutagenic in mammalian assays in vitro and in vivo. Braz. J. Med. Biol. Res. 2014;47:287–298. doi: 10.1590/1414-431X20143301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Park J.M., Kang T.H. Transcriptional and posttranslational regulation of nucleotide excision repair: the guardian of the genome against ultraviolet radiation. Int. J. Mol. Sci. 2016;17 doi: 10.3390/ijms17111840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Premi S., Han L., Mehta S., Knight J., Zhao D., Palmatier M.A., Kornacker K., Brash D.E. Genomic sites hypersensitive to ultraviolet radiation. Proc. Natl. Acad. Sci. U. S. A. 2019;116:24196–24205. doi: 10.1073/pnas.1907860116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Juckett D.A., Rosenberg B. Correlation of human longevity oscillations with sunspot cycles. Radiat. Res. 1993;133:312–320. [PubMed] [Google Scholar]
- 15.Ershova E.S., Sergeeva V.A., Tabakov V.J., Kameneva L.A., Porokhovnik L.N., Voronov, Khakina E.A., Troshin P.A., Kutsev S.I., Veiko N.N., et al. Functionalized fullerene increases NF-kappaB activity and blocks genotoxic effect of oxidative stress in serum-starving human embryo lung diploid fibroblasts. Oxid. Med. Cell. Longev. 2016;2016:9895245. doi: 10.1155/2016/9895245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Davis G.E., Jr., Lowell W.E. Solar energy at birth and human lifespan. J. Photochem. Photobiol., B. 2018;186:59–68. doi: 10.1016/j.jphotobiol.2018.07.006. [DOI] [PubMed] [Google Scholar]
- 17.Lucock M., Thota R., Garg M., Martin C., Jones P., Furst J., Yates Z., Jablonski N.G., Chaplin G., Veysey M., et al. Early lifecycle UV-exposure calibrates adult vitamin D metabolism: evidence for a developmentally originated vitamin D homeostat that may alter related adult phenotypes. Am. J. Hum. Biol. 2019;31 doi: 10.1002/ajhb.23272. [DOI] [PubMed] [Google Scholar]
- 18.Lucock, M., Glanville, T., Yates, Z., Walker, J., Furst, J., and Simpson, N. (2012). Solar cycle predicts folate-sensitive neonatal genotypes at discrete phases of the first trimester of pregnancy: a novel folate-related human embryo loss Hypothesis. Med. Hypotheses 79, 210-215. [DOI] [PubMed]
- 19.Lucock M.e.a. Photoperiod at conception predicts C677T-MTHFR genotype: a novel gene-environment interaction. Am. J. Hum. Biol. 2010;22:484–489. doi: 10.1002/ajhb.21022. [DOI] [PubMed] [Google Scholar]
- 20.Gluckman P.D., Hanson M.A., Beedle A.S. Early life events and their consequences for later disease: a life history and evolutionary perspective. Am. J. Hum. Biol. 2007;19:1–19. doi: 10.1002/ajhb.20590. [DOI] [PubMed] [Google Scholar]
- 21.Vaiserman A.M., Koliada A.K. Early-life adversity and long-term neurobehavioral outcomes: epigenome as a bridge? Hum. Genom. 2017;11:34. doi: 10.1186/s40246-017-0129-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Magalhaes S., Pugliatti M., Riise T., Myhr K.M., Ciampi A., Bjornevik K., Wolfson C. Shedding light on the link between early life sun exposure and risk of multiple sclerosis: results from the EnvIMS Study. Int. J. Epidemiol. 2019;48:1073–1082. doi: 10.1093/ije/dyy269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Skjærvø G.R., F F., R E. Solar activity at birth predicted infant survival and women's fertility in historical Norway. Proc. Biol. Sci. 2015;282:1801. doi: 10.1098/rspb.2014.2032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Cavalcante D.N., Sposito J.C., Crispim B.D., Nascimento A.V., Grisolia A.B. Genotoxic and mutagenic effects of passive smoking and urban air pollutants in buccal mucosa cells of children enrolled in public school. Toxicol. Mech. Methods. 2017;27:346–351. doi: 10.1080/15376516.2017.1288767. [DOI] [PubMed] [Google Scholar]
- 25.McGuinness A.J., Davis J.A., Dawson S.L., Loughman A., Collier F., O'Hely M., Simpson C.A., Green J., Marx W., Hair C., et al. A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Mol. Psychiatr. 2022 doi: 10.1038/s41380-022-01456-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Adan A., Archer S.N., Hidalgo M.P., Di Milia L., Natale V., Randler C. Circadian typology: a comprehensive review. Chronobiol. Int. 2012;29:1153–1175. doi: 10.3109/07420528.2012.719971. [DOI] [PubMed] [Google Scholar]
- 27.Torrey E.F., Miller J., Rawlings R., Yolken R.H. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr. Res. 1997;28:1–38. doi: 10.1016/s0920-9964(97)00092-3. [DOI] [PubMed] [Google Scholar]
- 28.Dean L. In: Medical Genetics Summaries. Pratt V.M., Scott S.A., Pirmohamed M., Esquivel B., Kane M.S., Kattman B.L., Malheiro andA.J., editors. 2012. Schizophrenia. (Bethesda (MD) [Google Scholar]
- 29.Hanwell H.E., Banwell B. Assessment of evidence for a protective role of vitamin D in multiple sclerosis. Biochim. Biophys. Acta. 2011;1812:202–212. doi: 10.1016/j.bbadis.2010.07.017. [DOI] [PubMed] [Google Scholar]
- 30.Alfredsson L., Armstrong B.K., Butterfield D.A., Chowdhury R., de Gruijl F.R., Feelisch M., Garland C.F., Hart P.H., Hoel D.G., Jacobsen R., et al. Insufficient sun exposure has become a real public health problem. Int. J. Environ. Res. Publ. Health. 2020;17 doi: 10.3390/ijerph17145014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Hart P.H., Norval M., Byrne S.N., Rhodes L.E. Exposure to ultraviolet radiation in the modulation of human diseases. Annu. Rev. Pathol. 2019;14:55–81. doi: 10.1146/annurev-pathmechdis-012418-012809. [DOI] [PubMed] [Google Scholar]
- 32.Bernard J.J., Gallo R.L., Krutmann J. Photoimmunology: how ultraviolet radiation affects the immune system. Nat. Rev. Immunol. 2019;19:688–701. doi: 10.1038/s41577-019-0185-9. [DOI] [PubMed] [Google Scholar]
- 33.Norval M., McLoone P., Lesiak A., Narbutt J. The effect of chronic ultraviolet radiation on the human immune system. Photochem. Photobiol. 2008;84:19–28. doi: 10.1111/j.1751-1097.2007.00239.x. [DOI] [PubMed] [Google Scholar]
- 34.Norval M., Halliday G.M. The consequences of UV-induced immunosuppression for human health. Photochem. Photobiol. 2011;87:965–977. doi: 10.1111/j.1751-1097.2011.00969.x. [DOI] [PubMed] [Google Scholar]
- 35.Phelan M., Seller J., Leese M. The routine assessment of severity amongst people with mental illness. Soc. Psychiatr. Psychiatr. Epidemiol. 2001;36:200–206. doi: 10.1007/s001270170064. [DOI] [PubMed] [Google Scholar]
- 36.Davis G.E., Lowell W.E. Using artificial neural networks and the Gutenberg-Richter power law to "rightsize" a behavioral health care system. Am. J. Med. Qual. 1999;14:216–228. doi: 10.1177/106286069901400505. [DOI] [PubMed] [Google Scholar]
- 37.Regier D.A., Narrow W.E., Rae D.S., Manderscheid R.W., Locke B.Z., Goodwin F.K. The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch. Gen. Psychiatr. 1993;50:85–94. doi: 10.1001/archpsyc.1993.01820140007001. [DOI] [PubMed] [Google Scholar]
- 38.Bak P. Copernicus, an imprint of Springer-Verlag; New York, NY: 1996. How Nature Works: the Science of Self-Organized Criticality. [Google Scholar]
- 39.Shigo A.L. Shigo & Trees Assoc.; Durham, New Hampshire: 1991. Modern Arboriculture. [Google Scholar]
- 40.Liu Y., Wheaton A.G., Croft J.B., Xu F., Cunningham T.J., Greenlund K.J. Relationship between sleep duration and self-reported health-related quality of life among US adults with or without major chronic diseases, 2014. Sleep Health. 2018;4:265–272. doi: 10.1016/j.sleh.2018.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Mandelbrot B. W. H. Freeman & Co.; New York, NY: 1977. The Fractal Geometry of Nature. [Google Scholar]
- 42.Watari S. Fractal dimensions of solar activity. Sol. Phys. 1995;158:365–377. [Google Scholar]
- 43.Zmeskal O. Entropy of fractal systems. Comput. Math. Appl. 2013;66:135–146. [Google Scholar]
- 44.Karlsson H., Dal H., Gardner R.M., Torrey E.F., Dalman C. Birth month and later diagnosis of schizophrenia. A population-based cohort study in Sweden. J. Psychiatr. Res. 2019;116:1–6. doi: 10.1016/j.jpsychires.2019.05.025. [DOI] [PubMed] [Google Scholar]
- 45.Hallgrimsson B., Willmore K., Hall B.K. Canalization, developmental stability, and morphological integration in primate limbs. Am. J. Phys. Anthropol. Suppl. 2002;35:131–158. doi: 10.1002/ajpa.10182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Mancuso S.G., Morgan V.A., Mitchell P.B., Berk M., Young A., Castle D.J. A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: results from the Second Australian national psychosis survey. J. Affect. Disord. 2015;172:30–37. doi: 10.1016/j.jad.2014.09.035. [DOI] [PubMed] [Google Scholar]
- 47.Chan K.A., Tsoulis M.W., Sloboda D.M. Early-life nutritional effects on the female reproductive system. J. Endocrinol. 2015;224:R45–62. doi: 10.1530/JOE-14-0469. [DOI] [PubMed] [Google Scholar]
- 48.Gong W., Liang Q., Zheng D., Zhong R., Wen Y., Wang X. Congenital heart defects of fetus after maternal exposure to organic and inorganic environmental factors: a cohort study. Oncotarget. 2017;8:100717–100723. doi: 10.18632/oncotarget.20110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Schnittker J. Season of birth and depression in adulthood: revisiting historical forerunner evidence for in-utero effects. SSM Popul. Health. 2018;4:307–316. doi: 10.1016/j.ssmph.2018.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Bralet M.C., Loas G., Yon V., Marechal V. Clinical characteristics and risk factors for Kraepelinian subtype of schizophrenia: replication of previous findings and relation to summer birth. Psychiatr. Res. 2002;111:147–154. doi: 10.1016/s0165-1781(02)00148-8. [DOI] [PubMed] [Google Scholar]
- 51.Darrell-Berry H., Berry K., Bucci S. The relationship between paranoia and aggression in psychosis: a systematic review. Schizophr. Res. 2016;172:169–176. doi: 10.1016/j.schres.2016.02.009. [DOI] [PubMed] [Google Scholar]
- 52.Kirkpatrick B., Castle D., Murray R.M., Carpenter W.T., Jr. Risk factors for the deficit syndrome of schizophrenia. Schizophr. Bull. 2000;26:233–242. doi: 10.1093/oxfordjournals.schbul.a033443. [DOI] [PubMed] [Google Scholar]
- 53.Kirkpatrick B., Mucci A., Galderisi S. Primary, enduring negative symptoms: an update on research. Schizophr. Bull. 2017;43:730–736. doi: 10.1093/schbul/sbx064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Iasevoli F., Avagliano C., Altavilla B., Barone A., D'Ambrosio L., Matrone M., Notar Francesco D., Razzino E., de Bartolomeis A. Disease severity in treatment resistant schizophrenia patients is mainly affected by negative symptoms, which mediate the effects of cognitive dysfunctions and neurological soft signs. Front. Psychiatr. 2018;9:553. doi: 10.3389/fpsyt.2018.00553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Burkhardt E., Pfennig A., Breitling G., Pfeiffer S., Sauer C., Bechdolf A., Correll C.U., Bauer M., Leopold K. Creativity in persons at-risk for bipolar disorder-A pilot study. Early Interv. Psychiat. 2019;13:1165–1172. doi: 10.1111/eip.12748. [DOI] [PubMed] [Google Scholar]
- 56.MacCabe J.H., Sariaslan A., Almqvist C., Lichtenstein P., Larsson H., Kyaga S. Artistic creativity and risk for schizophrenia, bipolar disorder and unipolar depression: a Swedish population-based case-control study and sib-pair analysis. Br. J. Psychiatry. 2018;212:370–376. doi: 10.1192/bjp.2018.23. [DOI] [PubMed] [Google Scholar]
- 57.Santosa C.M., Strong C.M., Nowakowska C., Wang P.W., Rennicke C.M., Ketter T.A. Enhanced creativity in bipolar disorder patients: a controlled study. J. Affect. Disord. 2007;100:31–39. doi: 10.1016/j.jad.2006.10.013. [DOI] [PubMed] [Google Scholar]
- 58.Greenwood T.A. Creativity and bipolar disorder: a shared genetic vulnerability. Annu. Rev. Clin. Psychol. 2020;16:239–264. doi: 10.1146/annurev-clinpsy-050718-095449. [DOI] [PubMed] [Google Scholar]
- 59.Johnson S.L., Murray G., Fredrickson B., Youngstrom E.A., Hinshaw S., Bass J.M., Deckersbach T., Schooler J., Salloum I. Creativity and bipolar disorder: touched by fire or burning with questions? Clin. Psychol. Rev. 2012;32:1–12. doi: 10.1016/j.cpr.2011.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Taylor K., Fletcher I., Lobban F. Exploring the links between the phenomenology of creativity and bipolar disorder. J. Affect. Disord. 2015;174:658–664. doi: 10.1016/j.jad.2014.10.040. [DOI] [PubMed] [Google Scholar]
- 61.Legrand A., Iftimovici A., Khayachi A., Chaumette B. Epigenetics in bipolar disorder: a critical review of the literature. Psychiatr. Genet. 2021;31:1–12. doi: 10.1097/YPG.0000000000000267. [DOI] [PubMed] [Google Scholar]
- 62.Tondo L., Vazquez G.H., Baldessarini R.J. Depression and mania in bipolar disorder. Curr. Neuropharmacol. 2017;15:353–358. doi: 10.2174/1570159X14666160606210811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Veleva B.I., van Bezooijen R.L., Chel V.G.M., Numans M.E., Caljouw M.A.A. Effect of ultraviolet light on mood, depressive disorders and well-being. Photodermatol. Photoimmunol. Photomed. 2018;34:288–297. doi: 10.1111/phpp.12396. [DOI] [PubMed] [Google Scholar]
- 64.Rosenthal N.E., Sack D.A., Gillin J.C., Lewy A.J., Goodwin F.K., Davenport Y., Mueller P.S., Newsome D.A., Wehr T.A. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch. Gen. Psychiatr. 1984;41:72–80. doi: 10.1001/archpsyc.1984.01790120076010. [DOI] [PubMed] [Google Scholar]
- 65.Kroon J.S., Wohlfarth T.D., Dieleman J., Sutterland A.L., Storosum J.G., Denys D., de Haan L., Sturkenboom M.C. Incidence rates and risk factors of bipolar disorder in the general population: a population-based cohort study. Bipolar Disord. 2013;15:306–313. doi: 10.1111/bdi.12058. [DOI] [PubMed] [Google Scholar]
- 66.Armbruster B., Gross G., Huber G. Long-term prognosis and course of schizo-affective, schizophreniform, and cycloid psychoses. Psychiatr. Clin. 1983;16:156–168. doi: 10.1159/000283964. [DOI] [PubMed] [Google Scholar]
- 67.Miller J.N., Black D.W. Schizoaffective disorder: a review. Ann. Clin. Psychiatr. 2019;31:47–53. [PubMed] [Google Scholar]
- 68.Azorin J.M., Kaladjian A., Fakra E. [Current issues on schizoaffective disorder] Encephale. 2005;31:359–365. doi: 10.1016/s0013-7006(05)82401-7. [DOI] [PubMed] [Google Scholar]
- 69.Cheniaux E., Landeira-Fernandez J., Lessa Telles L., Lessa J.L., Dias A., Duncan T., Versiani M. Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders. J. Affect. Disord. 2008;106:209–217. doi: 10.1016/j.jad.2007.07.009. [DOI] [PubMed] [Google Scholar]
- 70.Tarbox S.I., Brown L.H., Haas G.L. Diagnostic specificity of poor premorbid adjustment: comparison of schizophrenia, schizoaffective disorder, and mood disorder with psychotic features. Schizophr. Res. 2012;141:91–97. doi: 10.1016/j.schres.2012.07.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Pagel T., Baldessarini R.J., Franklin J., Baethge C. Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder. Bipolar Disord. 2013;15:229–239. doi: 10.1111/bdi.12057. [DOI] [PubMed] [Google Scholar]
- 72.Rybakowski J.K. 120th anniversary of the kraepelinian dichotomy of psychiatric disorders. Curr. Psychiatr. Rep. 2019;21:65. doi: 10.1007/s11920-019-1048-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Parker G. How well does the DSM-5 capture schizoaffective disorder? Can. J. Psychiatr. 2019;64:607–610. doi: 10.1177/0706743719856845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Kalmanti E., Maris T.G. Fractal dimension as an index of brain cortical changes throughout life. Vivo. 2007;21:641–646. [PubMed] [Google Scholar]
- 75.Mathger L.M., Shashar N., Hanlon R.T. Do cephalopods communicate using polarized light reflections from their skin? J. Exp. Biol. 2009;212:2133–2140. doi: 10.1242/jeb.020800. [DOI] [PubMed] [Google Scholar]
- 76.Ottosen L.D., Hindkjaer J., Ingerslev J. Light exposure of the ovum and preimplantation embryo during ART procedures. J. Assist. Reprod. Genet. 2007;24:99–103. doi: 10.1007/s10815-006-9081-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Nayak G., Zhang K.X., Vemaraju S., Odaka Y., Buhr E.D., Holt-Jones A., Kernodle S., Smith A.N., Upton B.A., D'Souza S., et al. Adaptive thermogenesis in mice is enhanced by opsin 3-dependent adipocyte light sensing. Cell Rep. 2020;30:672–686 e678. doi: 10.1016/j.celrep.2019.12.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Goldstein J.M. Impact of prenatal maternal cytokine exposure on sex differences in brain circuitrry regulating stress in offspring 45 years later. Proc. Natl. Acad. Sci. Unit. States Am. 2021;118 doi: 10.1073/pnas.2014464118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Fernandez D.C., Fogerson P.M., Lazzerini Ospri L., Thomsen M.B., Layne R.M., Severin D., Zhan J., Singer J.H., Kirkwood A., Zhao H., et al. Light affects mood and learning through distinct retina-brain pathways. Cell. 2018;175:71–84 e18. doi: 10.1016/j.cell.2018.08.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Disanto G., Morahan J.M., Lacey M.V., DeLuca G.C., Giovannoni G., Ebers G.C., Ramagopalan S.V. Seasonal distribution of psychiatric births in England. PLoS One. 2012;7 doi: 10.1371/journal.pone.0034866. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Woodberry K.A., Shapiro D.I., Bryant C., Seidman L.J. Progress and future directions in research on the psychosis prodrome: a review for clinicians. Harv. Rev. Psychiatr. 2016;24:87–103. doi: 10.1097/HRP.0000000000000109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.McFarlane W.R., Susser E., McCleary R., Verdi M., Lynch S., Williams D., McKeague I.W. Reduction in incidence of hospitalizations for psychotic episodes through early identification and intervention. Psychiatr. Serv. 2014;65:1194–1200. doi: 10.1176/appi.ps.201300336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Lerchl A. Month of birth and life expectancy: role of gender and age in a comparative approach. Naturwissenschaften. 2004;91:422–425. doi: 10.1007/s00114-004-0553-5. [DOI] [PubMed] [Google Scholar]
- 84.Gavrilov L.A., Gavrilova N.S. Season of birth and exceptional longevity: comparative study of american centenarians, their siblings, and spouses. J. Aging Res. 2011;2011:104616. doi: 10.4061/2011/104616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Doblhammer G., Vaupel J.W. Lifespan depends on month of birth. Proc. Natl. Acad. Sci. U. S. A. 2001;98:2934–2939. doi: 10.1073/pnas.041431898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Lummaa V., Tremblay M. Month of birth predicted reproductive success and fitness in pre-modern Canadian women. Proc. Biol. Sci. 2003;270:2355–2361. doi: 10.1098/rspb.2003.2507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Ueda P., Edstedt Bonamy A.K., Granath F., Cnattingius S. Month of birth and cause-specific mortality between 50 and 80 years: a population-based longitudinal cohort study in Sweden. Eur. J. Epidemiol. 2014;29:89–94. doi: 10.1007/s10654-014-9882-7. [DOI] [PubMed] [Google Scholar]
- 88.Ueda P., Edstedt Bonamy A.K., Granath F., Cnattingius S. Month of birth and mortality in Sweden: a nation-wide population-based cohort study. PLoS One. 2013;8 doi: 10.1371/journal.pone.0056425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Abel E.L., Kruger M.L. Birth month affects longevity. Death Stud. 2010;34:757–763. doi: 10.1080/07481181003772499. [DOI] [PubMed] [Google Scholar]
- 90.Dobson R., Giovannoni G., Ramagopalan S. The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude. J. Neurol. Neurosurg. Psychiatry. 2013;84:427–432. doi: 10.1136/jnnp-2012-303934. [DOI] [PubMed] [Google Scholar]
- 91.Pantavou K.G., Bagos P.G. Season of birth and multiple sclerosis: a systematic review and multivariate meta-analysis. J. Neurol. 2020;267:2815–2822. doi: 10.1007/s00415-019-09346-5. [DOI] [PubMed] [Google Scholar]
- 92.Staples J., Ponsonby A.L., Lim L. Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis. BMJ. 2010;340:c1640. doi: 10.1136/bmj.c1640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Akhtar S., Alroughani R., Al-Shammari A., Al-Abkal J., Ayad Y. Month of birth and risk of multiple sclerosis in Kuwait: a population-based registry study. Mult. Scler. 2015;21:147–154. doi: 10.1177/1352458514541578. [DOI] [PubMed] [Google Scholar]
- 94.Capriati T., Francavilla R., Castellaneta S., Ferretti F., Diamanti A. Impact of the birth's season on the development of celiac disease in Italy. Eur. J. Pediatr. 2015;174:1657–1663. doi: 10.1007/s00431-015-2589-2. [DOI] [PubMed] [Google Scholar]
- 95.Assa A., Waisbourd-Zinman O., Daher S., Shamir R. Birth month as a risk factor for the diagnosis of celiac disease later in life: a population-based study. J. Pediatr. Gastroenterol. Nutr. 2018;67:367–370. doi: 10.1097/MPG.0000000000002001. [DOI] [PubMed] [Google Scholar]
- 96.Nilsson L., Bjorksten B., Hattevig G., Kjellman B., Sigurs N., Kjellman N.I. Season of birth as predictor of atopic manifestations. Arch. Dis. Child. 1997;76:341–344. doi: 10.1136/adc.76.4.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Karachaliou F.H., Panagiotopoulou K., Manousakis M., Sinaniotis K., Papageorgiou F. Month of birth, atopic disease, and sensitization to common aeroallergens in Greece. Pediatr. Allergy Immunol. 1995;6:216–219. doi: 10.1111/j.1399-3038.1995.tb00289.x. [DOI] [PubMed] [Google Scholar]
- 98.Sargsyan A., Gupta J., Ghosh D. Association of Severe Atopic Dermatitis with month of birth in Armenian pediatric patients. Pediatr. Allergy Immunol. 2018;29:655–656. doi: 10.1111/pai.12918. [DOI] [PubMed] [Google Scholar]
- 99.Lee L.C., Newschaffer C.J., Lessler J.T., Lee B.K., Shah R., Zimmerman A.W. Variation in season of birth in singleton and multiple births concordant for autism spectrum disorders. Paediatr. Perinat. Epidemiol. 2008;22:172–179. doi: 10.1111/j.1365-3016.2007.00919.x. [DOI] [PubMed] [Google Scholar]
- 100.Lee B.K., Gross R., Francis R.W., Karlsson H., Schendel D.E., Sourander A., Reichenberg A., Parner E.T., Hornig M., Yaniv A., et al. Birth seasonality and risk of autism spectrum disorder. Eur. J. Epidemiol. 2019;34:785–792. doi: 10.1007/s10654-019-00506-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Shalev H., Solt I., Chodick G. Month of birth and risk of autism spectrum disorder: a retrospective cohort of male children born in Israel. BMJ Open. 2017;7 doi: 10.1136/bmjopen-2016-014606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Sucksdorff M., Brown A.S., Chudal R., Surcel H.M., Hinkka-Yli-Salomaki S., Cheslack-Postava K., Gyllenberg D., Sourander A. Maternal vitamin D levels and the risk of offspring attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry. 2021;60:142–151 e142. doi: 10.1016/j.jaac.2019.11.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Kahn H.S., Morgan T.M., Case L.D., Dabelea D., Mayer-Davis E.J., Lawrence J.M., Marcovina S.M., Imperatore G., Group S.f.D. Association of type 1 diabetes with month of birth among U.S. youth: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009;32:2010–2015. doi: 10.2337/dc09-0891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Grover V., Lipton R.B., Sclove S.L. Seasonality of month of birth among African American children with diabetes mellitus in the city of Chicago. J. Pediatr. Endocrinol. Metab. 2004;17:289–296. doi: 10.1515/jpem.2004.17.3.289. [DOI] [PubMed] [Google Scholar]
- 105.Thvilum M., Brandt F., Brix T.H., Hegedus L. Month of birth is associated with the subsequent diagnosis of autoimmune hypothyroidism. A nationwide Danish register-based study. Clin. Endocrinol. 2017;87:832–837. doi: 10.1111/cen.13425. [DOI] [PubMed] [Google Scholar]
- 106.Kyrgios I., Giza S., Tsinopoulou V.R., Maggana I., Haidich A.B., Galli-Tsinopoulou A. Seasonality of month of birth in children and adolescents with autoimmune thyroiditis: a continuing conundrum. J. Pediatr. Endocrinol. Metab. 2018;31:1123–1131. doi: 10.1515/jpem-2018-0051. [DOI] [PubMed] [Google Scholar]
- 107.Francis N.K., Curtis N.J., Noble E., Cortina-Borja M., Salib E. Is month of birth a risk factor for colorectal cancer? Gastroenterol. Res. Pract. 2017;2017:5423765. doi: 10.1155/2017/5423765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Dauvilliers Y., Carlander B., Molinari N., Desautels A., Okun M., Tafti M., Montplaisir J., Mignot E., Billiard M. Month of birth as a risk factor for narcolepsy. Sleep. 2003;26:663–665. doi: 10.1093/sleep/26.6.663. [DOI] [PubMed] [Google Scholar]
- 109.Brenner A.V., Linet M.S., Shapiro W.R., Selker R.G., Fine H.A., Black P.M., Inskip P.D. Season of birth and risk of brain tumors in adults. Neurology. 2004;63:276–281. doi: 10.1212/01.wnl.0000129984.01327.9d. [DOI] [PubMed] [Google Scholar]
- 110.Schmidt L.S., Grell K., Frederiksen K., Johansen C., Schmiegelow K., Schuz J. Seasonality of birth in children with central nervous system tumours in Denmark, 1970-2003. Br. J. Cancer. 2009;100:185–187. doi: 10.1038/sj.bjc.6604813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Langagergaard V., Norgard B., Mellemkjaer L., Pedersen L., Rothman K.J., Sorensen H.T. Seasonal variation in month of birth and diagnosis in children and adolescents with Hodgkin disease and non-Hodgkin lymphoma. J. Pediatr. Hematol. Oncol. 2003;25:534–538. doi: 10.1097/00043426-200307000-00007. [DOI] [PubMed] [Google Scholar]
- 112.Crump C., Sundquist J., Sieh W., Winkleby M.A., Sundquist K. Season of birth and risk of Hodgkin and non-Hodgkin lymphoma. Int. J. Cancer. 2014;135:2735–2739. doi: 10.1002/ijc.28909. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Basta N.O., James P.W., Craft A.W., McNally R.J. Seasonal variation in the month of birth in teenagers and young adults with melanoma suggests the involvement of early-life UV exposure. Pigment Cell Melanoma Res. 2011;24:250–253. doi: 10.1111/j.1755-148X.2010.00791.x. [DOI] [PubMed] [Google Scholar]
- 114.Lin S.W., Wheeler D.C., Park Y., Spriggs M., Hollenbeck A.R., Freedman D.M., Abnet C.C. Prospective study of ultraviolet radiation exposure and mortality risk in the United States. Am. J. Epidemiol. 2013;178:521–533. doi: 10.1093/aje/kws589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Van Ranst M., Joossens M., Joossens S., Van Steen K., Pierik M., Vermeire S., Rutgeerts P. Crohn's disease and month of birth. Inflamm. Bowel Dis. 2005;11:597–599. doi: 10.1097/01.mib.0000163697.34592.d4. [DOI] [PubMed] [Google Scholar]
- 116.Davies G., Welham J., Chant D., Torrey E.F., McGrath J. A systemic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophr. Bull. 2003;29:587–593. doi: 10.1093/oxfordjournals.schbul.a007030. [DOI] [PubMed] [Google Scholar]
- 117.Pazderska A., Fichna M., Mitchell A.L., Napier C.M., Gan E., Ruchala M., Santibanez-Koref M., Pearce S.H. Impact of month of birth on the risk of development of autoimmune addison's disease. J. Clin. Endocrinol. Metab. 2016;101:4214–4218. doi: 10.1210/jc.2016-2392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Stoupel E., Abramson E., Fenig E. Birth month of patients with malignant neoplasms: links to longevity? J. Basic Clin. Physiol. Pharmacol. 2012;23:57–60. doi: 10.1515/jbcpp-2012-0025. [DOI] [PubMed] [Google Scholar]
- 119.Yuen J., Ekbom A., Trichopoulos D., Hsieh C.C., Adami H.O. Season of birth and breast cancer risk in Sweden. Br. J. Cancer. 1994;70:564–568. doi: 10.1038/bjc.1994.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data included in article/supplementary material/referenced in article.





